Research Topic · Peer-Reviewed

Covid Variant Vaccines

COVID variant vaccines are immunizations developed or adapted to maintain protection against evolving variants of SARS-CoV-2, the virus that causes COVID-19. As the virus replicates, mutations accumulate, particularly in the spike glycoprotein that mediates cell entry and is the principal target of vaccine-induced i…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 20× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

COVID variant vaccines are immunizations developed or adapted to maintain protection against evolving variants of SARS-CoV-2, the virus that causes COVID-19. As the virus replicates, mutations accumulate, particularly in the spike glycoprotein that mediates cell entry and is the principal target of vaccine-induced immunity, and some changes can reduce the effectiveness of immunity raised against earlier strains. This drives the scientific need to track viral evolution and to update or design vaccines accordingly. Research relevant to this topic includes the molecular and evolutionary characterization of SARS-CoV-2 and its relationship to other coronaviruses, algorithmic prediction of possible spike mutations, and the immunological effects of spike-protein variation on interferon and cytokine responses. It also connects to the broader epidemiology of the pandemic, including models of transmission and outbreak risk and estimates of the immunization required to limit spread, as well as the information environment surrounding vaccines. Understanding variant vaccines therefore requires linking genomic surveillance to immunology and to population-level transmission dynamics. Sub-areas include viral mutation and spike-protein evolution, genomic surveillance and variant identification, the immunology of vaccine-induced protection against variants, and the modeling of vaccination strategy. By aligning vaccine design with the changing virus, variant vaccines aim to sustain immunity and reduce severe disease as SARS-CoV-2 continues to evolve.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 12 articles above have been cited 20 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Covid Variant Vaccines, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.